Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical TrialJAMA 2022 Jan 11;327(2)138-150, DM Rubino, FL Greenway, U Khalid, PM O'Neil, J Rosenstock, R Sørrig, TA Wadden, A Wizert, WT Garvey
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.